TORONTO, May 31 /PRNewswire-FirstCall/ - MDS Inc. , a leading provider of products and services to the global life sciences markets, announced that the Company will report second quarter results on Thursday June 7th.
The Company will also host an analyst conference call with Stephen P. DeFalco, President and Chief Executive Officer and Douglas Prince, Executive Vice-President Finance and Chief Financial Officer, to discuss the results with analysts later that morning. The call will be webcast live at 10:30 am EST on June 7th.
Interested parties may access the live webcast by visiting the “Latest News” section of the MDS home page at www.mdsinc.com and clicking on the conference link. An audio archive of the call and the presentation slides will also be available after the event on the “Webcasts & Presentations” page in our “For Investors” section of the MDS website.
MDS Inc. is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and the diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 6,200 highly skilled people in 28 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.
MDS Inc.
CONTACT: Investors: Sharon Mathers, Senior Vice-President, InvestorRelations and External Communications, MDS Inc., (416) 675-6777 x 34721,sharon.mathers@mdsinc.com; Media: Catherine Melville, Director, ExternalCommunications, MDS Inc., (416) 675-6777 x 32265,catherine.melville@mdsinc.com
